Genomic Health's Q3 Revenues Increase 17 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genomic Health reported after the close of the market Monday that its third-quarter revenues increased 17 percent year over year, and the firm posted a profit for the second quarter in a row.

The Redwood City, Calif.-based pharmacogenomic test maker brought in total revenues of $46.3 million, compared to revenues of $39.5 million for the third quarter of 2009. It beat analysts' consensus estimate of $44.9 million for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.